Business Description
PuraPharm Corporation Ltd
ISIN : KYG7306Y1044
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.17 | |||||
Debt-to-Equity | 3.16 | |||||
Debt-to-EBITDA | 24.22 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.57 | |||||
Beneish M-Score | -3.71 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14 | |||||
3-Year FCF Growth Rate | 13.7 | |||||
3-Year Book Growth Rate | -33.1 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.88 | |||||
9-Day RSI | 43.28 | |||||
14-Day RSI | 41.63 | |||||
6-1 Month Momentum % | -10.81 | |||||
12-1 Month Momentum % | -25.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.6 | |||||
Quick Ratio | 0.31 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 317.85 | |||||
Days Sales Outstanding | 108.27 | |||||
Days Payable | 260.97 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 26.8 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 51.97 | |||||
Operating Margin % | -5.99 | |||||
Net Margin % | -20.77 | |||||
FCF Margin % | 18.87 | |||||
ROE % | -52.25 | |||||
ROA % | -10.16 | |||||
ROIC % | -3.29 | |||||
ROC (Joel Greenblatt) % | -10.94 | |||||
ROCE % | -19.01 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 0.07 | |||||
PS Ratio | 0.55 | |||||
PB Ratio | 1.76 | |||||
Price-to-Tangible-Book | 2.9 | |||||
Price-to-Free-Cash-Flow | 2.9 | |||||
Price-to-Operating-Cash-Flow | 2.34 | |||||
EV-to-EBIT | -11.55 | |||||
EV-to-EBITDA | 36.1 | |||||
EV-to-Revenue | 1.47 | |||||
EV-to-FCF | 7.77 | |||||
Price-to-Projected-FCF | 1.41 | |||||
Earnings Yield (Greenblatt) % | -8.66 | |||||
FCF Yield % | 34.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
PuraPharm Corporation Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 419.405 | ||
EPS (TTM) (HK$) | -0.22 | ||
Beta | 0.39 | ||
Volatility % | 15.82 | ||
14-Day RSI | 41.63 | ||
14-Day ATR (HK$) | 0.033166 | ||
20-Day SMA (HK$) | 0.5995 | ||
12-1 Month Momentum % | -25.84 | ||
52-Week Range (HK$) | 0.51 - 0.95 | ||
Shares Outstanding (Mil) | 395.05 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PuraPharm Corporation Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PuraPharm Corporation Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
PuraPharm Corporation Ltd Frequently Asked Questions
What is PuraPharm Corporation Ltd(HKSE:01498)'s stock price today?
When is next earnings date of PuraPharm Corporation Ltd(HKSE:01498)?
Does PuraPharm Corporation Ltd(HKSE:01498) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |